CORPHED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Corphed, and what generic alternatives are available?
Corphed is a drug marketed by Fosun Pharma and Par Sterile Products and is included in two NDAs.
The generic ingredient in CORPHED is ephedrine sulfate. There are sixty-eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Corphed
A generic version of CORPHED was approved as ephedrine sulfate by SANDOZ on August 23rd, 2017.
Summary for CORPHED
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 5,256 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CORPHED at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CORPHED
US Patents and Regulatory Information for CORPHED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fosun Pharma | CORPHED | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088602-001 | Apr 11, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Par Sterile Products | CORPHEDRA | ephedrine sulfate | SOLUTION;INTRAVENOUS | 208943-001 | Jan 27, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |